[32F3-32F3];[33C1-33C1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
32F3;33C1
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC243 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d10374 to be at Release 3 genomic coordinate 12044040 on chromosome arm 2L. The Gene Disruption project determined the insertion site of P{XP}d10374 to be at Release 3 genomic coordinate 12044441 on arm 2L. This corresponds to 33C1 on both the Release 3 and Release 4 genome maps.
The predicted position of PBac{WH}f05591 on the Release 4 map is 32F3. Consequently, the cytological breakpoints of Df(3R)BSC243 are predicted to be 32F3;33C1.